TY - DATA T1 - Additional file 1: Table S1. of Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease PY - 2017/01/17 AU - Michael Mosteller AU - Maarten van den Berge AU - Louise Hosking AU - Wim Timens AU - Pieter Hiemstra AU - Courtney Crim AU - Dirkje Postma AU - Soumitra Ghosh UR - https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Genetic_evaluation_of_the_effect_of_GLCCI1_rs37973_on_corticosteroid_response_in_chronic_obstructive_pulmonary_disease/4560160 DO - 10.6084/m9.figshare.c.3667558_D1.v1 L4 - https://ndownloader.figshare.com/files/7385296 KW - Chronic obstructive pulmonary disease KW - Inhaled corticosteroids KW - Genetic association KW - GLCCI1 KW - Fluticasone furoate KW - Fluticasone propionate N2 - Clinical characteristics of patients with COPD by rs37973 genotype (Studies 1 and 2). Table S2. Clinical characteristics of patients with COPD by rs37973 genotype (GLUCOLD study). Appendix 1. Sensitivity analyses exploring the effect of transformation and covariate adjustment in Study 2. Table S3. The influence of transformation and covariate adjustment on the analysis of change in FEV1 versus rs37973 genotype in patients with COPD (Study 2). Appendix 2. List of Institutional Review Boards/Independent Ethics Committees and the Chairperson (s) for each site. (DOCX 68 kb) ER -